|Fastest Growing Market:||Asia-Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The medication adherence market is projected to register a CAGR of 15.0% during the forecast period (2022-2027).
COVID-19 pandemic has emphasized the need for reformation in the health care system for accessibility of medical care to patients in rural areas. Decentralization of the health system to the primary care level and utilization of teleophthalmology should be considered by healthcare planners in the future. Various research studies have provided insight into the application of medicine adherence during the pandemic. For instance, in November 2021, a research study published titled "The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases" stated that medical- and medication-related problems have arisen because of the restrictions put in place to reduce the spread of COVID-19, along with the fear of exposure to COVID-19. Understanding the consequences of the COVID-19 pandemic in people with chronic diseases is crucial to improving health care and outpatient pharmacy accessibility and resources for this population during this and future pandemics. Similarly, another research study published in January 2021, titled "Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries," stated that the contribution of community pharmacists in managing chronic conditions and promoting medication adherence is key to easing the disease burden on health systems. Hence, such studies will promote market growth in the upcoming future.
Factors such as the rising adoption of mhealth adherence services are expected to increase the market growth. Various research studies have provided insight into the advantages of mhealth adherence services. For instance, in March 2022, a research study published titled "A mHealth Intervention to Improve Medication Adherence and Health Outcomes Among Patients With Coronary Heart Disease: Randomized Controlled Trial" stated that the treatment of many chronic illnesses involves long-term pharmaceutical therapy, but it is an ongoing challenge to find effective ways to improve medication adherence to promote good health outcomes. Cardioprotective medications can prevent the enlargement of harmful clots, cardiovascular symptoms, and poor therapeutic outcomes, such as uncontrolled high blood pressure and hyperlipidemia, for patients with coronary heart disease. However, poor adherence to cardioprotective medications has been reported as a global health concern among patients with coronary heart disease, and it is particularly a concern in China. mHealth intervention can improve medication adherence and health outcomes, including systolic and diastolic blood pressure. Several end-user facilities have opted for better services in recent years. For instance, in December 2020, Baxter Regional Medical Center announced that it would discontinue its Baxter Regional CARE app at the end of the year. The 268-bed, Mountain Home-based hospital launched the direct-to-consumer app in early 2019, joining a wave of health systems developing on-demand urgent care services to reduce ER congestion and improve patient engagement. Baxter Regional will handle virtual care through its EHR-based TeleVisits platform, which includes the eClinicalWorks patient portal and Healow mHealth app. Such advancements and its adoptions will increase market growth in the upcoming future.
However, privacy and security concerns related to the services will likely hinder the market growth.
Scope of the Report
As per the scope, medication adherence is the extent to which the patient follows the doctor’s instructions about the timing, dosage, and frequency of prescribed medicines. The Medication Adherence Market is Segmented by Type (Hardware Centric, and Software Centric), Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.
|Central Nervous System|
Key Market Trends
Software Centric Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Partnership and mergers are other factors for the growth of the market. For instance, in February 2021, an article titled “Fighting “or medication adherence in the European Union: The Gravitate-Health project” stated t” at European citizens can obtain a great amount of information (online and offline) about any medicine. As already published by the OECD, poor medication adherence leads to more than 200,000 premature deaths yearly in Europe. As a response to this, a public-private partnership has emerged (01 November 2020) between more than 39 members in Europe and the US, under the co-leadership of the University of Oslo and Pfizer, and founded by the Innovative Medicines Initiative (IMI). This project has been given the name “Gravitate “Health Project.” This project was launched on 01 November 2020, with a scheduled duration of five years and a budget of EUR18,500,000. Such projects would increase market growth in the upcoming future. Product launch is another factor for the growth of the market. For instance, in October 2020, FDB and RxCap launched a new medication adherence mobile app. It includes the ability for patients to import their lists of prescribed medications along with access to medication instructions from Meducation. Additionally, the app can notify patients when to take their medications, record adherence, and alert designated caregivers if a medication is missed. Such launches would increase the market share.
To understand key trends, Download Sample Report
North America is Expected to Dominate the Market Over the Forecast Period
The North American region would dominate the market. Factors such as research studies would increase the market growth as it provides the cost-to-benefit ratio of implementing the services. An article published in 2022 by Ōmcare, titled "4 telling medication adherence statistics (updated for 2022)," stated that around 66% of people in the United States take at least one prescription medication. The average number of prescriptions taken is 4 per person, but that number rises significantly for those treating chronic conditions. Regardless, medication is one of the largest expenditures in the healthcare industry to date (over 10% of all healthcare spending). The same source stated that statistics show that between 40 and 60% of mentally ill patients have poor medication adherence and rarely take their medications on time, if at all.
Similarly, an article published by the CDC in August 2021, titled "Tailored Pharmacy-Based Interventions to Improve Medication Adherence," stated that CVD is a major driver of health care costs in the United States—with over USD 363.4 billion going toward health care services, medications, and lost productivity due to premature death each year. The implications of medication nonadherence are widespread and have financial impacts on health systems, providers, payers, and, most importantly, patients. In the United States, the costs of nonadherence to prescribed medications are high and place significant financial strains on the health care system. Hence, such studies would increase market growth.
Hence, the market is expected to grow due to the abovementioned factors.
To understand geography trends, Download Sample Report
The market is partially fragmented and consists of several major players. Some of the companies currently dominating the market are AdhereTech, McKesson Corporation, Omnicell, Inc., SMRxT INC, and DrFirst, among others.
- In January 2022, CareDx will expand its medication adherence services with the acquisition of the Transplant Pharmacy. The Transplant Pharmacy provides individualized transplant pharmacy services for patients at multiple transplant centers throughout the United States.
- In January 2021, CuePath Innovation Ltd announced that the company had signed a service agreement with The Care Company, an Ontario-based at-home care provider for seniors and chronic health patients. The agreement makes CuePath's Medication Adherence (MAAS) a standard service offering to The Care Company's growing client population.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for mHealth Technologies
4.2.2 Increasing Prevalence of Chronic Diseases
4.3 Market Restraints
4.3.1 Privacy and Security Concerns for Patient Data
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Type
5.1.1 Hardware Centric
5.1.2 Software Centric
5.2 By Medication
5.2.2 Central Nervous System
5.3.1 North America
18.104.22.168 United States
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
220.127.116.11 South Africa
18.104.22.168 Rest of Middle-East and Africa
5.3.5 South America
22.214.171.124 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.2 Cardinal Health
6.1.6 Johnson & Johnso
6.1.7 Koninklijke Philips N.V.
6.1.8 McKesson Corporation
6.1.9 MedAdvisor International Pty Ltd
6.1.10 Medminder Systems, Inc.
6.1.11 Omnicell, Inc.
6.1.12 SMRxT INC
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Medication Adherence market is studied from 2019 - 2027.
What is the growth rate of Global Medication Adherence?
The Global Medication Adherence is growing at a CAGR of 15% over the next 5 years.
Which region has highest growth rate in Global Medication Adherence?
Asia-Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Medication Adherence?
North America holds highest share in 2021.
Who are the key players in Global Medication Adherence?
AdhereTech, McKesson Corporation, Omnicell, Inc., SMRxT INC, DrFirst are the major companies operating in Global Medication Adherence.